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Takashi Suzuki1, Masahiko Morita1, Yoshinori Kobayashi2 and Ayako Kamimura1*
Abstract
Background: Many human studies report that nitric oxide (NO) improves sport performance. This is because NO is
a potential modulator of blood flow, muscle energy metabolism, and mitochondrial respiration during exercise.
L-Citrulline is an amino acid present in the body and is a potent endogenous precursor of L-arginine, which is a
substrate for NO synthase. Here, we investigated the effect of oral L-citrulline supplementation on cycling time
trial performance in humans.
Methods: A double-blind randomized placebo-controlled 2-way crossover study was employed. Twenty-two trained
males consumed 2.4 g/day of L-citrulline or placebo orally for 7 days. On Day 8 they took 2.4 g of L-citrulline or
placebo 1 h before a 4-km cycling time trial. Time taken to complete the 4 km cycle, along with power output/VO2
ratio (PO/VO2), plasma nitrite and nitrate (NOx) and amino acid levels, and visual analog scale (VAS) scores, was
evaluated.
Results: L-Citrulline supplementation significantly increased plasma L-arginine levels and reduced completion time by
1.5 % (p < 0.05) compared with placebo. Moreover, L-citrulline significantly improved subjective feelings of muscle
fatigue and concentration immediately after exercise.
Conclusions: Oral L-citrulline supplementation reduced the time take to complete a cycle ergometer exercise trial.
Trial registration: Current Controlled Trials UMIN000014278.
Keywords: Ergogenic, Human, L-Citrulline, Nitric oxide (NO), Sport performance
Background
NO plays key roles such as maintaining the function and
integrity of the endothelium, including vascular tone and
structure [1]. In sports physiology, nitrate supplementa-
tion is thought to be an ergogenic aid [2–4]. This view is
based on evidence that NO is an important modulator
of blood flow and mitochondrial respiration under
physiological conditions [5]. Some studies have shown
that dietary NO related supplements, such as nitrate-
rich beetroot juice, enhance human sport performance
[6–9]. Dietary supplementation with nitrate thus appears
to be beneficial for exercise.
There is growing interest in the use of L-citrulline as
an NO-related dietary ingredient. L-Citrulline is
present in the body and is a potent endogenous pre-
cursor of L-arginine [10], which is a substrate for NO
synthase (NOS). NOS catalyzes a complex enzymatic
reaction that leads to NO formation from L-arginine
and oxygen and generates L-citrulline as a byproduct [11].
L-Citrulline is effectively recycled via the L-citrulline NO
cycle to L-arginine and plays an important role in the me-
tabolism and regulation of NO [12]. L-Citrulline supple-
mentation has various beneficial effects, such as
ameliorating arterial stiffness [13] and improving erectile
function [14], memory [15], O2 uptake kinetics, and high-
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intensity exercise performance [16] through upregulation
of NO synthesis. We and others have demonstrated in
animal models that oral supplementation with L-citrulline
upregulates endothelial NO synthase (eNOS) expression,
improves endothelial function, and plays an atheroprotec-
tive role [17–19]. Interestingly, a clinical trial has shown
that oral intake of L-citrulline dose-dependently and more
effectively increases plasma L-arginine levels than does L-
arginine supplementation in healthy human volunteers
[20]. Therefore, L-citrulline may be considered an effective
L-arginine and NO supplies which might be expected to
have potential for enhancing sport performance. Some
studies have found that acute L-citrulline supplementation
has no effect on exercise [21, 22]. On the other hand, Bailey
et al. [16] showed that 6 days of L-citrulline supplementa-
tion improved exercise tolerance. This suggests that chronic
L-citrulline supplementation (for about 1 week) is needed
to enhance exercise tolerance. However, it is not presently
known whether chronic small doses of L-citrulline enhance
sport performance. Moreover, to our knowledge, no study
has comprehensively evaluated the effects of L-citrulline on
endurance exercise performance during simulated compe-
tition or on subjective feelings of discomfort associated
with exercise in humans. We hypothesized that chronic L-
citrulline administration would enhance performance dur-
ing simulated competition.
The aim of this study was to investigate the effect of
oral supplementation of L-citrulline on cycling time-trial
performance in healthy trained men.
Methods
Subjects
Twenty-five trained healthy Japanese males volunteered to
take part in this double-blind, randomized, placebo-
controlled, two-way crossover trial. Because of the cross-
over design, half of the subjects participated under one
condition and half under the other at the same time, with
a washout period of 3 weeks. Randomization was con-
ducted by using SAS 9.3 (SAS Institute Inc.). The subjects
recruited were aged 20 to 39 years and participated in
sport twice a week or more. The sports included athletics
(long distance running), baseball, cycling, soccer, triathlon,
and skiing. Current smokers, subjects taking medication
or dietary supplements for chronic conditions, and sub-
jects with injuries that could interfere with their perform-
ance were excluded. The participants’ health status was
assessed by both physical and laboratory examinations, in-
cluding an electrocardiogram and blood chemistry panel.
Three males were excluded from the analysis because they
had colds on the test day. We therefore analyzed a final
total of 22 males (mean ± SD age, 29 ± 8.4 years; body
mass, 74 ± 9.4 kg; height, 175 ± 4.1 cm; body mass index,
24 ± 3.3 kg/m2). The subjects were instructed not to
change their usual training volume or diet during the
7 days of the study. The protocol was conducted accord-
ing to the Declaration of Helsinki and was approved by
the Ethics Committee of Fukuda Clinic (Osaka, Japan). All
subjects gave their written informed consent.
Study design
The study was conducted at Fukuda Clinic (Osaka,
Japan). After enrollment, the subjects were randomized
into two groups to receive the following treatments once
a day for 1 week before the experimental day in a
double-blind fashion: 9 capsules consisting of 2.4 g of L-
citrulline (KYOWA HAKKO BIO CO., Ltd., Tokyo,
Japan) or 9 placebo capsules consisting of 2.4 g of corn-
starch (Nippon NSC Co., Ltd., Tokyo, Japan) before bed-
time. The indistinguishability of the capsules was
confirmed by the Ethics Committee of Fukuda Clinic
(Osaka, Japan). The purity of L-citrulline was analyzed
by using an amino acid analyzer (L-8900 Hitachi High-
Technologies Corporation, Tokyo, Japan) [23, 24]. There
is no recommended dose for L-citrulline intake to
enhance sport performance, but a dose of 6 or 8 g of L-
citrulline malate has been used in other studies [25, 26].
On the day before each test day, subjects were all given
the same meals, which they were required to finish by
9:00 PM; they then fasted overnight. The following
morning, blood pressure and heart rate were measured
and blood samples were collected. Thereafter, the sub-
jects had breakfast (a rice ball, about 180 kcal) to pro-
vide energy 1 h before intake of the 9 capsules of
placebo or L-citrulline. After the intake of placebo or L-
citrulline, the subjects rested quietly before takingpart in
a 4-km cycling time trial (TT). Before the TT, each sub-
ject completed a warm-up. The TT was performed on a
cycle ergometer (Aerobike 75XL2; Konami Sports & Life
Co., Ltd., Tokyo, Japan) [27] 1 h after of the intake of
placebo or L-citrulline. After the TT, blood samples were
collected from the brachial vein. The study design is
summarized in Fig. 1.
Physical working capacity test
Subjects completed a physical working capacity test to
determine work rate during the TT. Physical working
capacity is an index employed in performance diagnos-
tics to appraise the tested person’s aerobic performance
capacity. The protocol began with 3 min of 25-watt (W)
cycling, after which 3 min each of 75-W and 125-W cyc-
ling was imposed. Physical working capacity at 75 % of
the predicted maximum heart rate (PWC75%HRmax) was
determined from the relationship between HR in the
final 30 s and exercise work load in the above-
mentioned incremental exercise test. PWC75%HRmax was
evaluated as work load at 75 % of HRmax (=220 – age)
[28]. The subjects were then familiarized with the cycle
ergometer.
Suzuki et al. Journal of the International Society of Sports Nutrition  (2016) 13:6 Page 2 of 8
Time trial test
On Day 8, one hour after intake of 2.4 g of placebo or L-
citrulline, each subject performed the TT. The work rate
of each subject was set at 60 rpm and PWC75%HRmax.
Time to complete 4 km of cycling, power output (PO),
VO2, plasma nitrite and nitrate (NOx) levels, plasma
amino acid concentrations, and visual analog scale
(VAS) scores were evaluated. The computrainer ergome-
try system recorded PO every 10 s, and these values
were averaged for every 0.5 km completed in the TT to
create a PO profile. During the TT, breath-by-breath
pulmonary gas exchange and ventilation were measured
continuously (Aero Monitor AE-300S, Minato Medical
Science Co., Ltd., Osaka, Japan) [29–31]. These data
were also used to produce a PO/VO2 ratio, namely the
PO produced in watts per liter of O2 consumed per min
(W/L/min).
Visual analog scale
Subjects were asked to subjectively rate their degree of
discomfort on a VAS from 0 mm (excellent) to 100 mm
(poor) after the TT. The VAS was originally developed
for measuring pain level [32] and has also been used to
assess fatigue level [33].
Blood sample analyses
Blood samples were collected from the brachial vein;
5 mL was collected each time. Plasma samples were pre-
pared by collecting blood in an EDTA-2Na-containing
tube and kept on ice until centrifugation at 1700 g for
10 min at 4 °C. Plasma NOx was assayed via the Griess
reaction by using a colorimetric assay kit (Nitrate/Nitrite
Colorimetric Assay Kit, Cayman, Ann Arbor, MI, USA)
[34, 35]. To assess amino acids, the plasma sample was
deproteinized with 4 % sulfosalicylic acid (plasma to
20 % sulfosalicylic acid ratio = 0.3: 0.075 mL) for 30 min
on ice and then centrifuged at 1700 g for 10 min at 4 °C.
The supernatant was stored at −80 °C until analysis. The
concentrations of amino acids (L-valine, L-isoleucine, L-
leucine, L-arginine, and L-citrulline) in the plasma were
measured with an amino acid analyzer (L-8900 Hitachi
High-Technologies Corporation, Tokyo, Japan) [23, 24].
Statistical analyses
Values are shown as means ± S.E.M. Paired t-tests were
used to evaluate the significance of any differences be-
tween the placebo and L-citrulline groups. Analyses were
performed with SPSS Statistics 22 (IBM Japan, Ltd.,




Plasma amino acid concentrations are summarized in
Table 1. Seven days’ intake of L-citrulline significantly
increased the plasma L-arginine level. On Day 8, plasma
L-citrulline and L-arginine levels after TT were signifi-
cantly higher in the L-citrulline group than in the pla-
cebo group. Levels of plasma branched chain amino
acids (BCAAs: L-valine, L-isoleucine, L-leucine) were
significantly lower at pre-load and post-load in the L-cit-
rulline group than in the placebo group. There was no
significant difference in the level of plasma NOx
between the placebo and L-citrulline groups (Fig. 2).
Physical performance test
Mean TT completion times are displayed in Fig. 3, and
the accompanying PO profiles are shown in Fig. 4a. L-
Citrulline supplementation significantly reduced comple-
tion time compared with placebo, with a group mean re-
duction of 1.5 % (placebo: 578 ± 15 s, L-citrulline: 569 ±
14 s, p < 0.05, Fig. 3). Ingestion of L-citrulline increased
mean PO by 2 % (placebo = 189 ± 5 W vs. L-citrulline =
193 ± 5 W, p < 0.05, Fig. 4b). There was no significant
difference in VO2 response between placebo and L-
citrulline (Table 2). PO/VO2 tended to be higher in the
L-citrulline-supplemented group in three of six elapsed





















Fig. 1 Study design
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Visual analog scale
L-Citrulline significantly improved subjective feelings of
muscle fatigue, and concentration, immediately after
exercise (Fig. 6). A marked but not statistically signifi-
cant improvement in ease of pedaling was observed with
L-citrulline supplementation (p < 0.1).
Discussion
We demonstrated that oral supplementation with L-
citrulline at 2.4 g/day for 7 days significantly increased
plasma L-arginine levels. Moreover, intake of L-citrulline
for 7 days and I h before the TT significantly increased
plasma L-citrulline and L-arginine levels and enhanced
cycling TT performance. In addition, subjective feelings
of muscle fatigue, and concentration, right after exercise
were significantly improved with L-citrulline.
In this human trial, the subjects engaged in TT cycling
to allow us to evaluate their exercise performance. Com-
petitive sports typically require athletes to complete a
given distance in the shortest possible time. Time-to-
exhaustion tests are primarily measures of “exercise cap-
acity,” and because there is no competitive sports event
in which competition is based on time and distance
before exhaustion, tests of this type have limited physio-
logical validity [36]. It has also been reported that there
is no relationship between measured time-to-exhaustion
and actual cycling performance [37]. In contrast, the TT
protocol used here has a high level of physiological val-
idity [36], provides an accurate simulation of physio-
logical responses during competition [38], and is well
correlated with actual race performance [39]. Therefore,
L-citrulline intake might be expected to enhance per-
formance in real competitive sport. We used cornstarch
as the placebo and the study design was a double-blind
crossover; we expected that these factors would reduce
the placebo effect.
The improved TT performance after supplementation
with L-citrulline was the consequence of significantly
greater PO for the same VO2. Interestingly, there was a
Table 1 Plasma amino acid concentration on Day 8
before TT and before intake after TT and after intake
Placebo L-Citrulline Placebo L-Citrulline
L-Citrulline (nmol/ml) 39.3 ± 1.4 54.3 ± 11.0 40.0 ± 1.4 475 ± 37**
L-Arginine (nmol/ml) 110 ± 4 139 ± 7** 110 ± 4 192 ± 9**
BCAA (nmol/ml) (valine, isoleucine, leucine) 565 ± 15 553 ± 21* 518 ± 20 501 ± 15*
Values are means ± S.E.M. n = 22, * p < 0.05, ** p < 0.001, indicating a significant difference from placebo
Fig. 2 Changes in plasma NOx before and after a 4 km TT. Values















Fig. 3 Completion times of the 4 km TT after placebo or L-citrulline
supplementation. Values are means ± S.E.M. n= 22, * p< 0.05, indicating
a significant difference from placebo
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significant correlation between plasma NOx and PO/
VO2 after supplementation with L-citrulline but placebo
had no correlation (data not shown). This finding sug-
gests that the effects of L-citrulline on PO/VO2 may
have been related to improved plasma NO availability,
which in turn may have enhanced sport performance. In
sports nutrition, NO-related products are attracting a lot
of attention for their ergogenic effects. Many applied
studies in humans report that NO improves sports per-
formance. This is because NO is a potential modulator
of blood flow, muscle energy metabolism, and mito-
chondrial respiration during exercise [5, 6, 40, 41]. Diet-
ary supplementation with nitrate reduces the O2 cost of
submaximal cycling [6, 42], knee extensor exercise [43],
and treadmill walking and running [44]. L-Arginine is
the direct precursor of NO via NOS activity. Moreover,
oral intake of L-arginine improves sports performance in
healthy subjects [45–47]. However, a relatively large dose
(6 to 14.2 g/day) of L-arginine would be required for
beneficial effects on sports performance, because L-
arginine is degraded by arginase in the small intestine
and liver [48–50]. For this reason, some studies have
shown no effect of L-arginine on O2 cost and sports per-
formance [51, 52]. In contrast, L-citrulline is not metab-
olized in the intestine or liver [53]. On entering the
kidneys, vascular endothelium, and other tissues, L-
citrulline is readily converted to L-arginine, thus raising
plasma and tissue levels of L-arginine and enhancing
NO production [10]. We found here that oral intake of
L-citrulline increased not only L-citrulline levels but also
L-arginine levels. It has been reported that oral supple-
mentation with L-citrulline increases plasma L-arginine
levels more effectively than does L-arginine supplemen-
tation in healthy subjects [20], and increased plasma L-
arginine levels before exercise enhance sport perform-
ance [16]. However, some studies have found that oral
L-citrulline supplementation has no effect on exercise
[21, 22]. This is likely because a single dose of L-
citrulline is insufficient to enhance sport performance.
Bailey et al. [16] demonstrated that 6 days of L-citrulline
supplementation improved exercise tolerance. These
findings suggest that L-citrulline needs to be taken con-
tinuously (for about 1 week) to enhance exercise toler-
ance. This is why we conducted an 8-day trial, which
showed positive effects of L-citrulline. The daily dose of
L-citrulline in our study was 2.4 g. This seems smaller
than those used in other previous studies [16, 21, 22],
but 2 to 3 g of oral L-citrulline has been reported to in-
crease plasma L-arginine levels [20, 54]. Moinard et al.
[54] showed that the Cmax of plasma L-arginine was
146 μM when subjects consumed 2 g of L-citrulline. In
the study by Bailey et al. [16], the L-citrulline group had
a mean plasma L-arginine level of 135 μM and showed
improved exercise performance. Therefore, we had hy-
pothesized that 2.4 g/day of L-citrulline for 8 days might
be enough to increase plasma L-arginine levels such that






































Fig. 4 PO profile during the 4 km TT (a) and mean PO (b) of the 4 km TT after placebo or L-citrulline supplementation. Values are means ± S.E.M.
n = 22. * p < 0.05, indicating a significant difference from placebo




VO2 (mL/min) VO2 (mL/min)
0.0 ~ 0.5 1662 ± 236 1682 ± 255
0.5 ~ 1.0 2396 ± 311 2400 ± 341
1.0 ~ 1.5 2553 ± 319 2539 ± 386
1.5 ~ 2.0 2692 ± 353 2676 ± 381
2.0 ~ 2.5 2777 ± 346 2801 ± 369
2.5 ~ 3.0 2861 ± 344 2847 ± 363
3.0 ~ 3.5 2933 ± 361 2911 ± 377
3.5 ~ 4.0 3005 ± 381 2971 ± 397
Values are means ± S.E.M. n = 22
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reported that the plasma L-arginine level in their L-
citrulline group was about 2.3 times that in their placebo
group [16]. On the other hand, our data demonstrated
that the plasma L-arginine level in our L-citrulline group
was about 1.7 times that in our placebo group. However,
our absolute value of plasma L-arginine after intake of
L-citrulline was higher than that in the study by Bailey
et al. Therefore, 2.4 g/day of L-citrulline for 8 days is
likely enough to obtain ergogenic aid.
We found here that, L-citrulline supplementation sig-
nificantly increased plasma levels of plasma L-citrulline
and L-arginine, which are essential for NO synthesis. In
our study the plasma arginine level after supplementa-
tion of L-citrulline was as high as that in the study by
Bailey et al. [16]. Our results thus suggest that L-
citrulline would enhance sport performance through NO
synthesis; however, we were not able to observe an
increase in plasma NOx level. We measured NOx at
only two time points: before and after exercise, not dur-
ing exercise. These evaluation points might not have
been suitable for detecting significant between-point dif-
ferences in NO generation. Chemiluminescence assay is
more sensitive than colorimetric assay for detecting
NOx. In this study, we measured NOx by colorimetric
assay, and it may not have been sensitive enough to de-
tect changes in plasma NOx.
Sureda et al. [26] showed that oral intake of 6 g of L-
citrulline malate 2 h before exercise enhances the use of
BCAAs, which are metabolized in the muscles to pro-
duce energy. In our study, L-citrulline supplementation
decreased plasma BCAA levels. These data indicate that
L-citrulline promotes the metabolic use of these amino
acids as fuel to support muscular exercise. Moreover, L-
citrulline significantly improved subjective feelings of
muscular fatigue. BCAA reduces muscle soreness and
fatigue [55, 56]. Furthermore, L-citrulline malate reduces
fatigue and post-workout muscle soreness [25]; water-
melon juice, which is rich in L-citrulline, also reduces
muscle soreness [57]. Our data suggest that L-citrulline
has the potential to relieve muscle fatigue. Therefore,
the effects of L-citrulline on BCAA utilization and mus-
cular fatigue might also contribute to enhanced sport
performance. In addition, the subjective feeling of con-
centration was significantly improved by oral intake of
L-citrulline. Hayashi et al. have reported that L-citrulline
improves blood flow [17]. The concentration-enhancing
effects of L-citrulline are likely due to enhanced blood
flow.
A growing number of sport supplements include L-
arginine, which is claimed to enhance NO production,
despite L-arginine being rapidly metabolized in the small
intestine and liver when administered orally. As men-
tioned above, L-citrulline is a potent precursor of L-
Fig. 5 PO/VO2 during the 4 km TT after placebo or L-citrulline supplementation. Values are means ± S.E.M. n = 22
Fig. 6 Subjective feelings immediately after exercise. Values are means
± S.E.M. n= 22. * p< 0.05, indicating a significant difference from placebo
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arginine, and several functional advantages of L-citrulline
over L-arginine have been elucidated [17, 20]; more-
over, Akashi et al. [58] have revealed that L-citrulline is
an efficient hydroxyl radical scavenger. L-arginine tends
to be extremely bitter and highly water absorbent,
whereas L-citrulline is tasteless, odorless, and non-
hygroscopic. It would thus appear that L-citrulline is
superior to L-arginine in terms of ease of handling and
taste as an ingredient of supplements. L-Citrulline is
present in large quantities in watermelon but is not
abundant in other fruits, vegetables, meat, or fish
because it is a free amino acid. It is difficult to obtain
L-citrulline from a conventional diet in sufficient
amounts to enhance sports performance. Therefore, it
may be beneficial to take a few tablets of L-citrulline
before exercise as an ergogenic aid.
Our study had several limitations. We instructed the
subjects not to change their training volumes and to eat
their usual diets during the 7 days of the study. However,
we did not make the training volumes and diets identical
among the subjects, with the exception of dinner on the
evening before the test day and breakfast on the test day.
Some of the subjects’ performances may have been
affected by intense training sessions in the 2 days before
the trials. Here, we conducted a double-blind random-
ized placebo-controlled two-way crossover study in 22
subjects; in future, an additional, larger-scale study will
be needed to verify our findings.
Conclusions
We conclude that oral L-citrulline supplementation
enhances cycling time trial performance. Moreover, L-
citrulline improves subjective feelings (e.g. of muscle
soreness) after performance. These data, taken together,
suggest that L-citrulline is a promising amino acid for
enhancing sport performance.
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